U.S.-Japan Pilot Project In Pre-Market Collaboration Begins Soon
FDA and its Japanese counterpart will soon name the two devices - one American, one Japanese - they will use in a new pilot project that could lead to faster market access for products destined for both markets, according to CDRH's Carole Carey
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Despite headwinds, executives remain optimistic about growth in Abbott’s medical devices and diabetes divisions and plan several product rollouts, including the Volt PFA catheter for electrophysiology and the dual glucose-ketone sensor CGM.
An “NHS Innovator Passport” that allows quicker uptake of proven technologies across the national healthcare provider is one of the wins the UK government is looking to score from its new Life Sciences Sector plan. The plan majors on prevention. The medtech industry has given it a cautious welcome.
The exemption, which President Donald Trump announced on July 17, is intended to cut the risk of critical device shortages. Stakeholders say the technology needed to cut emissions to required levels is not yet widely available.